Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01172210 · ClinicalTrials.gov registry record
Examining Common Substrates of Eating and Alcohol Use Disorders
A clinical trial of Bulimia Nervosa and Alcohol Use Disorders, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 61
- Enrollment target
- 1
- Study location
NCT01172210: Completed study of Bulimia Nervosa and Alcohol Use Disorders, sponsored by New York State Psychiatric Institute.
NCT01172210 is a study of Bulimia Nervosa and Alcohol Use Disorders that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 61 participants, below the 1,735-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01172210, a study of Bulimia Nervosa and Alcohol Use Disorders, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
A substantial percentage of individuals with bulimia nervosa (BN) also meet criteria for a co-occurring substance use disorder, such as alcohol abuse or dependence; however, research examining this sub-group of patients with BN is limited. Understanding characteristics common to both eating and alcohol use disorders may enhance understanding of the mechanisms that could contribute to the co-occurrence and perpetuation of these disorders. Individuals with BN and alcohol use disorders appear to share some behavioral traits, and therefore, the primary aim of the current study is to compare patients with BN with and without an alcohol use disorder and normal controls on measures assessing an individual's mood and ability to perform certain tasks. Participants will be asked to complete computer-administered and paper-and-pencil assessments and two laboratory test meals on separate days. By probing the underpinnings of BN and alcohol use disorders, the investigators can determine whether these disorders have a shared diathesis, which will lay an essential foundation for future research to examine biological and genetic correlates of these disorders. Finally, as little is known about the treatment of patients with BN and a co-occurring alcohol use disorder, an exploratory aim of the current study is evaluate the suitability and efficacy of a 20-session cognitive-behavioral treatment (CBT) addressing both bulimic symptoms and alcohol use.
Conditions Studied
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2009-07 |
| Est. Completion | 2014-06 |
What the finished NCT01172210 record still lists
NCT01172210 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,735-participant average among 23 other Bulimia Nervosa trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Bulimia Nervosa appearing as the primary indexed condition, and to 0 interventions.
NCT01172210 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01172210 about?
NCT01172210 is a clinical study titled "Examining Common Substrates of Eating and Alcohol Use Disorders". A substantial percentage of individuals with bulimia nervosa (BN) also meet criteria for a co-occurring substance use disorder, such as alcohol abuse or dependence; however, research examining this sub-group of patients with BN is limited. Understanding characteristics common to both eating and alco...
What is the current status of trial NCT01172210?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2009-07. Estimated completion is 2014-06.
What conditions does trial NCT01172210 study?
This clinical trial studies the following conditions: Bulimia Nervosa, Alcohol Use Disorders.
Who is sponsoring clinical trial NCT01172210?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01172210 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bulimia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01172210's enrollment target sits among peer trials
61 12th of 23 higher than 12 of 23 other Bulimia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bulimia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Changes in Inhibition and Valuation After Eating
RECRUITING · NA
-
Eating Disorders Genetics Initiative 2
RECRUITING
-
Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa
RECRUITING
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Neurobiological and Psychological Maintenance Mechanisms Associated With Anticipatory Reward in Bulimia Nervosa
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia